Source: Interface Blog

Interface Blog Confluent Medical Technologies Acquires Biomedical Structures and Modified Polymer Components; Combining Nitinol and Catheter Capabilities With Implantable Textiles and Precision Polymers Capabilities

FREMONT, Calif.-(BUSINESS WIRE)-Confluent Medical Technologies ("Confluent Medical") today completed the acquisition of ETE Medical and its operating subsidiaries Biomedical Structures ("BMS") and Modified Polymer Components ("MPC"). Confluent Medical itself was formed in 2015 through the acquisition of Interface Catheter Solutions by Nitinol Devices and Components. BMS specializes in the development and manufacturing of biomedical textileThe post Confluent Medical Technologies Acquires Biomedical Structures and Modified Polymer Components; Combining Nitinol and Catheter Capabilities With Implantable Textiles and Precision Polymers Capabilities appeared first on Confluent Medical.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Gary D. Curtis's photo - President & CEO of Interfaceusa

President & CEO

Gary D. Curtis

CEO Approval Rating

70/100

Read more